clinical trial retatrutide A new from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one of the next major medications in the rapidly growing weight loss and diabetes Eli Lilly infiltrates anti-obesity market

Lee DH, Keum N, Hu FB, et al

We are used to doing informed consent for surgery and procedures but not equally good at doing informed consent before prescribing medications

While these findings provide preliminary evidence of the potential benefit of semaglutide in CUD in real-world populations further preclinical studies are warranted to understand the underlying mechanism and randomized clinical trials are needed to support its use clinically for CUD

Front Aging Neurosci 10:178

Frequently cited work includes publications by Sikiric et al

To manage nausea, I encourage my patients to stay well-hydrated with a sugar-free electrolyte beverage and to emphasize protein